Spanish Red Biotech Pipeline

Gilead Sciences

Simtuzumab

Type: Biodrugs/ Drugs
Therapeutic area: Digestive System
Indication: Liver fibrosis, primary sclerosing cholangitis, nonalcoholic steatohaepatitis
Phase: 2Phase II in Spain, 1Phase I